$112.51 Million in Sales Expected for CareMax, Inc. (NASDAQ:CMAX) This Quarter

Wall Street analysts predict that CareMax, Inc. (NASDAQ:CMAX) will post $112.51 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for CareMax’s earnings. The highest sales estimate is $123.91 million and the lowest is $101.12 million. The company is scheduled to report its next quarterly earnings results on Friday, November 12th.

On average, analysts expect that CareMax will report full year sales of $437.38 million for the current financial year, with estimates ranging from $420.42 million to $454.33 million. For the next fiscal year, analysts anticipate that the firm will report sales of $640.79 million, with estimates ranging from $631.38 million to $650.19 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow CareMax.

CareMax (NASDAQ:CMAX) last posted its quarterly earnings results on Thursday, August 12th. The company reported ($0.26) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.22).

Several research firms have recently commented on CMAX. Zacks Investment Research lowered shares of CareMax from a “hold” rating to a “sell” rating in a report on Wednesday, September 15th. Piper Sandler raised shares of CareMax from a “neutral” rating to an “overweight” rating and set a $14.00 price target for the company in a report on Monday, September 13th. Finally, Cowen began coverage on shares of CareMax in a report on Thursday, September 9th. They issued an “outperform” rating and a $14.00 price target for the company.

Several hedge funds have recently added to or reduced their stakes in the business. FMR LLC bought a new stake in shares of CareMax in the 2nd quarter worth approximately $74,241,000. Athyrium Capital Management LP bought a new stake in shares of CareMax in the 2nd quarter worth approximately $50,008,000. Perceptive Advisors LLC bought a new stake in shares of CareMax in the 2nd quarter worth approximately $42,828,000. Maverick Capital Ltd. bought a new stake in shares of CareMax in the 2nd quarter worth approximately $38,114,000. Finally, Alyeska Investment Group L.P. bought a new stake in shares of CareMax in the 2nd quarter worth approximately $29,973,000.

Shares of NASDAQ:CMAX traded down $0.16 during trading on Tuesday, hitting $8.95. The company’s stock had a trading volume of 335,837 shares, compared to its average volume of 680,636. The company has a quick ratio of 7.96, a current ratio of 7.96 and a debt-to-equity ratio of 0.25. CareMax has a fifty-two week low of $6.53 and a fifty-two week high of $18.42. The firm’s 50 day simple moving average is $9.15.

About CareMax

CareMax Medical Group, LLC operates as a health care organization that offers medical services through physicians and health care professionals. The company offers primary care, specialty care, telemedicine, health and wellness, optometry, dental, and transportation services. CareMax Medical Group, LLC was founded in 2011 and is based in Miami, Florida.

Featured Article: How Short Selling Works

Get a free copy of the Zacks research report on CareMax (CMAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CareMax (NASDAQ:CMAX)

Receive News & Ratings for CareMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareMax and related companies with MarketBeat.com's FREE daily email newsletter.